Gibson Dunn has advised Merck. Cooley has advised Cidara Therapeutics. Merck has entered into a definitive agreement to acquire Cidara Therapeutics, Inc., a biotechnology company specializing…
Merck Acquires Cidara Therapeutics in $9.2 Billion Transaction

























